β-Amyloid 29-40

β-Amyloid 29-40 is a synthetic peptide fragment derived from the C-terminal region of the amyloid beta (Aβ) protein, a sequence highly relevant in neurodegenerative research. Comprising amino acids 29 to 40 of the full-length Aβ peptide, this compound is utilized extensively in the study of amyloidogenic processes, protein aggregation, and the molecular underpinnings of neurological disorders. Its well-defined sequence and aggregation propensity make it a valuable biochemical tool for dissecting the structural and functional aspects of amyloid formation, as well as for developing and validating analytical methods targeting amyloidogenic peptides.

Peptide aggregation studies: As a defined segment of the amyloid beta sequence, β-Amyloid 29-40 is widely employed to investigate the mechanisms of peptide aggregation and fibrillogenesis. Researchers use it to model the self-assembly behavior of amyloidogenic peptides in vitro, enabling the systematic exploration of conditions that modulate oligomerization and fibril formation. These studies provide critical insights into the physicochemical factors driving amyloid aggregation, which are central to understanding the pathogenesis of protein misfolding diseases.

Neurotoxicity modeling: The peptide serves as an essential reagent for in vitro neurotoxicity assays, where its ability to form aggregates is harnessed to evaluate cellular responses to amyloidogenic stress. By exposing neuronal or glial cell cultures to β-Amyloid 29-40, investigators can assess cytotoxic effects, oxidative stress induction, and downstream signaling events associated with amyloid exposure. This application supports the identification of molecular mechanisms underlying amyloid-induced cellular dysfunction and facilitates the screening of protective compounds or interventions.

Analytical method development: β-Amyloid 29-40 is frequently used as a standard or reference material in the development and validation of bioanalytical techniques such as mass spectrometry, high-performance liquid chromatography (HPLC), and immunoassays. Its defined sequence and known aggregation properties enable precise calibration, sensitivity assessment, and specificity testing for methods intended to detect or quantify amyloid peptides in complex biological samples. These analytical applications are essential for advancing biomarker discovery and for ensuring the reliability of amyloid quantification in research settings.

Structure-activity relationship (SAR) studies: The fragment is a valuable model for probing the structure-activity relationships within the amyloid beta family. By comparing the biochemical and biophysical properties of β-Amyloid 29-40 to other Aβ fragments or full-length peptides, researchers can delineate sequence determinants of aggregation kinetics, toxicity, and interaction with cellular components. Such SAR investigations inform the design of peptide-based modulators, inhibitors, or imaging agents targeting amyloidogenic pathways.

Peptide-protein interaction analysis: β-Amyloid 29-40 is also utilized to elucidate interactions between amyloidogenic peptides and other biomolecules, including chaperones, enzymes, or small-molecule ligands. By incorporating the peptide into binding assays or co-incubation experiments, scientists can characterize affinity, binding sites, and the impact of such interactions on aggregation behavior. These studies contribute to the broader understanding of molecular chaperoning, amyloid clearance mechanisms, and the identification of potential therapeutic targets within the context of protein misfolding research.

1. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

2. Cationic cell-penetrating peptides are potent furin inhibitors

3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

4. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

5. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment